Teva CEO Says Drugmaker Will Fight US Price-Fixing Charges (2)
Teva to Cut Up to 25% of Israel Workforce, Calcalist Says - Bloomberg
Teva Pharmaceuticals CEO steps down as shares continue descent - BNN Bloomberg
Teva Is On The Prowl And Its Investors Are Taking Notice | Mint
Teva Agrees to Stop Selling Amgen Generic Following Patent Infringement Settlement | Ctech
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%
Activist Investor Jana Partners Takes Stake in Teva, Report Says | Ctech
Teva's CEO Was $2.8 Billion Down on His Second Day on the Job - Bloomberg
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
How Uggs, Hoka, and Tevas Helped Build Deckers' $2.5 Billion Ugly-Shoe Empire - Bloomberg
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva: Reportedly Planning Thousands of Layoffs in the U.S. | Fortune
Teva buys Allergan: 3 reasons why it's a blockbuster deal | Fortune
Teva looks to sell generics in China through joint venture with Guangzhou Pharma: Bloomberg | Fierce Pharma
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York state - KTVZ
Teva, Allergan Ready To Pay $5B To Settle Lawsuits Related To Opioid Painkillers: Bloomberg
Teva, Allergan ready to pay $5B to settle thousands of opioid lawsuits (TEVA) | Seeking Alpha
The Difficulties of Cloning a CEO - Bloomberg
Teva Plunges as U.S. Sales Drop Amid Generic Price Erosion
Actavis CEO: Teva-Mylan deal could be "value-destroying" - גלובס
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva's U.S. Unit Charged in Generic-Drug Price-Fixing Probe
Kare Schultz, president and chief executive officer of Teva... News Photo - Getty Images
